US EditionHealth Canada approves Tzield – the first ever disease modifying therapy for type 1 diabetes
Summary by breakthrought1d.ca
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
All
Left
Center
Right
Health Canada approves Tzield – the first ever disease modifying therapy for type 1 diabetes
On May 5, 2025, Sanofi announced Health Canada approval of Tzield, the first disease-modifying therapy for type 1 diabetes (T1D). This is a huge win for the T1D community in that it is the first medicine to be approved in Canada that addresses the autoimmunity behind T1D – not just the symptoms that is causes. […]
Health Canada has Granted Approval for Tzield®, the First and Only Disease-modifying Therapy in Autoimmune Type 1 Diabetes in Canada - Life Sciences British Columbia
Health Canada has issued a Notice of Compliance for Tzield®, a first-in-class disease-modifying therapy for autoimmune type 1 diabetes.
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
